tiprankstipranks
Advertisement
Advertisement
Rani Therapeutics Announces $20 Million Equity Financing
PremiumCompany AnnouncementsRani Therapeutics Announces $20 Million Equity Financing
1M ago
Nasdaq Delisting Risk Looms as Rani Therapeutics Fails to Meet $1 Minimum Bid Price
Premium
Company Announcements
Nasdaq Delisting Risk Looms as Rani Therapeutics Fails to Meet $1 Minimum Bid Price
2M ago
Rani Therapeutics Faces Nasdaq Bid Price Noncompliance Notice
Premium
Company Announcements
Rani Therapeutics Faces Nasdaq Bid Price Noncompliance Notice
2M ago
Rani Therapeutics reports Q4 EPS (7c), consensus (7c)
PremiumThe FlyRani Therapeutics reports Q4 EPS (7c), consensus (7c)
3M ago
Rani Therapeutics Holdings options imply 17.3% move in share price post-earnings
Premium
The Fly
Rani Therapeutics Holdings options imply 17.3% move in share price post-earnings
3M ago
RANI Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RANI Upcoming Earnings Report: What to Expect?
3M ago
Rani Therapeutics initiates Phase 1 study of RT-114 RaniPill
PremiumThe FlyRani Therapeutics initiates Phase 1 study of RT-114 RaniPill
6M ago
Rani Therapeutics finalizes governance and capital structure changes
Premium
Company Announcements
Rani Therapeutics finalizes governance and capital structure changes
6M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100